Genetics of Inherited Eye Disease
The Genetics of Inherited Eye Disease
The Genetics of Inherited Eye Disease
Sponsor study identifier
Secondary identifiers
observational
1,500
1 country
1
Study Start
June 22, 2015
Actual (reported)Primary Completion
September 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
September 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Background: Research has identified some of the genes involved in inherited eye diseases. But for many of these diseases, the genes are not yet known. Researchers want to try to find these genes. They also hope to learn more about how symptoms differ in people with similar gene changes. Objective: To learn more about genes involved in eye diseases. Eligibility: People who have a known or suspected inherited eye disease, and their relatives. Design:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 12, 2015
Actual (reported)June 15, 2015
Actual (reported)June 22, 2015
Actual (reported)September 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
September 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Establish cohort
Establish an initial "critical mass" of participants and knowledge to develop disease-specific protocols for specific inherited eye conditions.
Ongoing
Suggest best clinical outcome measures
ongoing
Revealing systematic comorbidities
ongoing
Provide a mechanism for collecting biological samples
ongoing
Determine the genetic cause(s) and molecular pathogenesis
ongoing
Participants with eye disease
Unaffected first degree relatives of participants with a known or suspected inherited eye disease.
A total of 1500 participants may be enrolled into this study. One thousand one-hundred (1,100) participants with known or suspected eye diseases and 400 healthy volunteers (unaffected relatives of affected participants) will be accrued for this study. Self-referral is permitted and participants may enroll as a referral from another NEI study.
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Bender C, Woo EG, Guan B, Ullah E, Feng E, Turriff A, Tumminia SJ, Sieving PA, Cukras CA, Hufnagel RB. Predominant Founder Effect among Recurrent Pathogenic Variants for an X-Linked Disorder. Genes (Basel). 2022 Apr 12;13(4):675. doi: 10.3390/genes13040675.
Laryssa A Huryn, M.D.
National Eye Institute (NEI)
First Submitted
June 12, 2015
First Posted
June 15, 2015
Study Start
June 22, 2015
Actual (reported)Primary Completion
September 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Contact the study team to confirm eligibility.
Study Completion
September 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 29, 2026
Record last verified: 2026-09-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: